CAINI, PATRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 4.873
EU - Europa 2.901
AS - Asia 1.658
SA - Sud America 161
AF - Africa 52
OC - Oceania 38
Totale 9.683
Nazione #
US - Stati Uniti d'America 4.812
RU - Federazione Russa 1.042
SG - Singapore 486
IT - Italia 480
CN - Cina 360
PL - Polonia 347
HK - Hong Kong 309
SE - Svezia 283
IE - Irlanda 255
VN - Vietnam 172
BR - Brasile 127
KR - Corea 125
DE - Germania 115
FI - Finlandia 83
FR - Francia 83
GB - Regno Unito 67
UA - Ucraina 67
JP - Giappone 47
IN - India 42
TR - Turchia 42
CA - Canada 38
AU - Australia 37
CI - Costa d'Avorio 24
NL - Olanda 19
AR - Argentina 14
MX - Messico 14
BE - Belgio 13
JO - Giordania 13
BD - Bangladesh 12
IQ - Iraq 10
CH - Svizzera 8
EC - Ecuador 8
ZA - Sudafrica 7
CZ - Repubblica Ceca 6
ES - Italia 6
PK - Pakistan 6
EG - Egitto 5
ID - Indonesia 5
NG - Nigeria 5
RO - Romania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
MA - Marocco 4
DK - Danimarca 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
MT - Malta 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 9.683
Città #
Santa Clara 1.110
Ashburn 463
Fairfield 394
Warsaw 347
Singapore 346
Chandler 280
Dublin 255
Hong Kong 252
San Jose 250
Woodbridge 201
Seattle 178
Wilmington 165
Cambridge 156
Beijing 150
Houston 130
Seoul 125
Ann Arbor 115
Jacksonville 103
Milan 84
Buffalo 80
The Dalles 75
Princeton 61
Los Angeles 60
Ho Chi Minh City 54
Lauterbourg 52
Altamura 50
Boston 48
Tokyo 47
Lawrence 45
Boardman 44
Hanoi 39
Rome 38
Dallas 37
Izmir 35
Melbourne 35
Bremen 34
Florence 34
Munich 31
Medford 29
New York 28
Mumbai 27
Abidjan 24
Shanghai 21
Hefei 20
San Diego 20
Paris 19
Turku 18
Washington 16
Moscow 15
Brussels 13
Falls Church 13
Naples 13
Norwalk 13
Toronto 11
London 10
São Paulo 10
Turin 10
Verona 10
Bern 8
Bologna 8
Frankfurt am Main 8
Helsinki 8
Kent 8
Redondo Beach 8
Brooklyn 7
Chicago 7
Da Nang 7
Atlanta 6
Bari 6
Brasília 6
Council Bluffs 6
Figino 6
Hillsboro 6
Orem 6
Palermo 6
Salerno 6
Stockholm 6
West Jordan 6
Abuja 5
Auburn Hills 5
Baghdad 5
Clifton 5
Frankfurt Am Main 5
Mexico City 5
Modena 5
Montreal 5
Rio de Janeiro 5
Tashkent 5
Venice 5
Andover 4
Barnet 4
Bergamo 4
Brescia 4
Brno 4
Cluj-Napoca 4
Denver 4
Jakarta 4
Manchester 4
Amsterdam 3
Biên Hòa 3
Totale 6.575
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 319
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 269
The effects of phosphate on the contraction of single skeletal myofibrils 236
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 231
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 221
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 216
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 209
Host genetic determinants in HCV-related mixed cryoglobulinemia 205
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 202
Host genetic determinants in HCV-related mixed cryoglobulinemia 198
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 196
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 192
Analysis of HCV persistence in patients with sustained virological response 190
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 187
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 185
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 179
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 177
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 176
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 176
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 176
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 175
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 174
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 172
Involvement of PI3K in HCV-related lymphoproliferative disorders 171
Host genetic determinants in HCV-related mixed cryoglobulinemia 169
T(14;18) translocation in chronic hepatitis C virus infection 165
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 165
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 165
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 162
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 162
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 158
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 156
Crioglobulinemia e linfoma in corso di infezione da HCV 151
Hepatitis C virus core protein enhances B lymphocyte proliferation 150
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 149
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 149
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 148
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 147
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 143
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 141
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 139
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 138
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 137
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 135
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 129
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 127
Eventi Oncomolecolari nella Crioglobulinemia Mista 123
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 122
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 121
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 120
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 109
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 105
Reply: HCV infection and psychopathological disorders 99
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 99
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 95
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 94
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 91
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 91
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 89
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 87
La cimentazione della proteina CD81 con ligandi specifici promuove la proliferazione di cellule B e l’espressione della proteina c-myc 86
null 48
Totale 9.696
Categoria #
all - tutte 25.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022431 4 49 15 15 15 17 16 30 21 9 90 150
2022/20231.154 100 152 75 108 114 226 152 59 124 8 21 15
2023/2024363 17 52 68 28 23 66 7 65 8 8 10 11
2024/20252.856 93 286 178 434 966 368 43 171 99 58 90 70
2025/20262.605 353 345 154 114 251 103 314 104 291 178 62 336
2026/202757 57 0 0 0 0 0 0 0 0 0 0 0
Totale 9.696